Medicare Enrolled
Dr. Samarth Reddy, M.D.
Medical Oncology · Boca Raton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reddy
Dr. Samarth Reddy is a medical oncology in Boca Raton, FL, with 20 years in practice. Based on federal Medicare data, Dr. Reddy performed 106,075 Medicare services across 3,580 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $9,735 from 67 pharmaceutical and/or device companies across 499 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 24% volume in FL$ $9,735 industry payments
Medicare Practice Summary
Medicare Utilization ↗106,075
Medicare services
Top 24% in FL for medical oncology
3,580
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,304 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 25,500 | $0 | $3 |
| Pembrolizumab injection (Keytruda) | 24,800 | $43 | $138 |
| Anti-nausea injection (aprepitant) | 9,100 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 8,100 | $18 | $49 |
| Epoetin alfa injection (Retacrit) for anemia | 6,891 | $6 | $28 |
| Iron sucrose injection (Venofer) | 6,600 | $0 | $3 |
| Epoetin alfa injection (Procrit) for anemia | 4,400 | $6 | $23 |
| Iron infusion (Monoferric) | 4,188 | $16 | $57 |
| Complete blood count (CBC) with differential | 3,547 | $8 | $31 |
| Blood draw (venipuncture) | 3,384 | $8 | $9 |
| Dexamethasone injection (steroid) | 2,138 | $0 | $2 |
| Office visit, established patient (30-39 min) | 2,049 | $101 | $338 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,420 | $1 | $41 |
| Drug injection, under skin or into muscle | 563 | $11 | $71 |
| Office visit, established patient (20-29 min) | 491 | $70 | $234 |
| Administration of chemotherapy into vein, 1 hour or less | 485 | $105 | $406 |
| Injection of additional new drug or substance into vein | 367 | $13 | $67 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 261 | $23 | $91 |
| Administration of additional new drug or substance into vein, 1 hour or less | 238 | $53 | $198 |
| Administration of chemotherapy into vein, each additional hour | 204 | $23 | $88 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 156 | $52 | $204 |
| New patient office visit (45-59 min) | 154 | $126 | $487 |
| Injection, diphenhydramine hcl, up to 50 mg | 149 | $1 | $3 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 126 | $59 | $213 |
| Infusion into a vein for hydration, each additional hour | 96 | $10 | $43 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 75 | $134 | $608 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 74 | $28 | $98 |
| New patient office visit, complex (60-74 min) | 74 | $178 | $610 |
| Infusion, normal saline solution , 1000 cc | 68 | $2 | $7 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 64 | $1 | $6 |
| Red blood count, automated test | 63 | $4 | $10 |
| Administration of additional new drug or substance into vein using push technique | 59 | $45 | $177 |
| Infusion into a vein for hydration, 31-60 minutes | 54 | $25 | $166 |
| Telephone medical discussion with physician, 11-20 minutes | 45 | $71 | $158 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 41 | $1 | $6 |
| Red blood count automated, with additional calculations | 38 | $5 | $20 |
| Office visit, established patient (10-19 min) | 13 | $47 | $144 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
28.6% high complexity
61.7% medium
9.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,735
Total received (2018-2024)
Avg $1,391/year across 7 years
Top 44% in FL for medical oncology
67
Companies
499
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,431 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$304 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,486
2023$1,728
2022$851
2021$682
2020$616
2019$616
2018$757
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,403
PFIZER INC.
$1,006
E.R. Squibb & Sons, L.L.C.
$919
Novartis Pharmaceuticals Corporation
$592
GENZYME CORPORATION
$353
Celgene Corporation
$343
Tempus AI, Inc
$343
AstraZeneca Pharmaceuticals LP
$328
GlaxoSmithKline, LLC.
$321
Genentech USA, Inc.
$300
Amgen Inc.
$280
Merck Sharp & Dohme LLC
$212
ABBVIE INC.
$196
Q Biomed Inc.
$180
Lilly USA, LLC
$167
Daiichi Sankyo Inc.
$167
Astellas Pharma US Inc
$148
Merck Sharp & Dohme Corporation
$140
Seagen Inc.
$136
BeiGene USA, Inc.
$129
EISAI INC.
$124
SERVIER PHARMACEUTICALS LLC
$118
Pharmacosmos Therapeutics Inc.
$100
Sumitomo Pharma America, Inc.
$92
Exelixis Inc.
$89
Incyte Corporation
$89
Bayer Healthcare Pharmaceuticals Inc.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$76
EMD Serono, Inc.
$72
TAIHO ONCOLOGY, INC.
$69
Adaptive Biotechnologies Corporation
$62
Deciphera Pharmaceuticals Inc.
$61
Gilead Sciences, Inc.
$57
Pharmacyclics LLC, An AbbVie Company
$56
Rigel Pharmaceuticals, Inc.
$52
AbbVie Inc.
$42
ImmunoGen, Inc.
$42
Eisai Inc.
$39
Cumberland Pharmaceuticals, Inc.
$37
Mirati Therapeutics, Inc.
$37
Agios Pharmaceuticals, Inc.
$37
Stemline Therapeutics Inc.
$35
ARRAY BIOPHARMA INC
$35
Janssen Pharmaceuticals, Inc
$35
Teva Pharmaceuticals USA, Inc.
$32
AbbVie, Inc.
$31
JAZZ PHARMACEUTICALS INC.
$31
Shield Therapeutics Inc
$29
Fennec Pharmaceuticals, Inc.
$27
SOBI, INC
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Octapharma USA, Inc.
$26
Kyowa Kirin, Inc.
$25
Ipsen Biopharmaceuticals, Inc
$25
Kite Pharma, Inc.
$24
Alexion Pharmaceuticals, Inc.
$24
Legend Biotech USA Inc.
$23
Davol Inc.
$22
SpringWorks Therapeutics, Inc.
$22
Regeneron Healthcare Solutions, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$21
Myovant Sciences Inc.
$19
Sirtex Medical Inc
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$16
Foundation Medicine, Inc.
$15
Sobi, Inc
$14
TESARO, Inc.
$13
Top 3 companies account for 34.2% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · Alecensa · BENDEKA · BOSULIF · BRUKINSA · Blincyto · CABOMETYX · CARVYKTI · COSELA · DARZALEX · DOPTELET · ELAHERE · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · Enhertu · Erleada · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · IDHIFA · IMBRUVICA · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MONOFERRIC · MYLOTARG · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Pedmark · Phesgo · Polivy · Pomalyst · Poteligeo · Progel · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rituxan Hycela · SANCUSO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · STRONTIUM CHLORIDE Sr-89 · SUTENT · TAGRISSO · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Venclexta · XALKORI · XARELTO · XGEVA · XT CDX · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
27
Per 100K population
1.8
County median income
$81,115
Nearest hospital
WEST BOCA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 24% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Reddy performed 25,500 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $9,735 from 67 companies across 499 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other medical oncologys in Boca Raton?
Dr. Reddy's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Boca Raton
Browse medical oncologys in Boca Raton ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology